Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
4.026
Zitationen
12
Autoren
2000
Jahr
Abstract
In patients with rheumatoid arthritis, treatment with rofecoxib, a selective inhibitor of cyclooxygenase-2, is associated with significantly fewer clinically important upper gastrointestinal events than treatment with naproxen, a nonselective inhibitor.
Ähnliche Arbeiten
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
1980 · 12.001 Zit.
International Journal of Molecular Sciences
2024 · 10.235 Zit.
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
1971 · 8.600 Zit.
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 · 5.748 Zit.
In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
2019 · 4.235 Zit.